Cyclosporine and Laboratory test abnormal - a phase IV clinical study of FDA data

Summary:

Laboratory test abnormal is reported as a side effect among people who take Cyclosporine (cyclosporine), especially for people who are 60+ old, have been taking the drug for < 1 month also take Soliris, and have Paroxysmal nocturnal haemoglobinuria.

The phase IV clinical study analyzes which people have Laboratory test abnormal when taking Cyclosporine. It is created by eHealthMe based on reports of 58,335 people who have side effects when taking Cyclosporine from the FDA, and is updated regularly.

What is Cyclosporine?

Cyclosporine has active ingredients of cyclosporine. It is often used in psoriasis. eHealthMe is studying from 58,714 Cyclosporine users. Check the latest studies of Cyclosporine.

What is Laboratory test abnormal?

Laboratory test abnormal is found to be associated with 1,195 drugs and 1,590 conditions by eHealthMe. Check the latest studies of Laboratory test abnormal.

On Jul, 22, 2026

58,335 people reported to have side effects when taking Cyclosporine.
Among them, 55 people (0.09%) have Laboratory test abnormal.

Could Cyclosporine cause Laboratory test abnormal?

Among these 55 people:

How long have people been on Cyclosporine when they have Laboratory test abnormal? *

What is the age of people who have Laboratory test abnormal when taking Cyclosporine? *

What are other drugs people take besides Cyclosporine? *

What are other side effects people have besides Laboratory test abnormal? *

Haemoglobin Decreased: 14 people, 25.45%
Thrombocytopenia (decrease of platelets in blood): 11 people, 20.00%
Nausea (feeling of having an urge to vomit): 10 people, 18.18%
Blood Lactate Dehydrogenase Increased: 10 people, 18.18%
Nausea And Vomiting: 9 people, 16.36%
White Blood Cell Count Decreased: 8 people, 14.55%
Haematocrit Decreased: 8 people, 14.55%
Fever: 8 people, 14.55%
Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 12.73%
Red Blood Cell Count Decreased: 7 people, 12.73%

What are the existing conditions these people have? *

Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 13 people, 23.64%
Aplastic Anemia: 7 people, 12.73%
Pain: 4 people, 7.27%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 5.45%
Diabetes: 3 people, 5.45%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 5.45%
High Blood Pressure: 3 people, 5.45%
Thyroid Diseases: 2 people, 3.64%
Rashes (redness): 2 people, 3.64%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 3.64%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclosporine and have Laboratory test abnormal?

- Check whether Laboratory test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cyclosporine:

Cyclosporine (58,714 reports)

Browse all side effects of Cyclosporine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Laboratory test abnormal:

Laboratory test abnormal (1,195 drugs)

Browse all the conditions that are associated with Laboratory test abnormal:

Laboratory test abnormal (1,590 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Cyclosporine) and Cyclosporine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.